Pre-made Tirnovetmab benchmark antibody ( Whole mAb (Canine), anti-IL31 (Canine) therapeutic antibody) for drug discovery and mechanism of action (MOA) research
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-Made Tirnovetmab biosimilar, Whole mAb (Canine): Anti-IL31 (Canine) therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
| Products Name (INN Index) | Pre-Made Tirnovetmab biosimilar, Whole mAb (Canine): Anti-IL31 (Canine) therapeutic antibody |
|---|---|
| INN Name | Tirnovetmab |
| Target | IL31 (Canine) |
| Format | Canine Whole mAb |
| Derivation | NA |
| Species Reactivity | Canine |
| CH1 Isotype | IgG2 |
| VD LC | Kappa |
| Highest_Clin_Trial (Jan '20) | Unknown |
| Est. Status | Active |
| 100% SI Structure | None |
| 99% SI Structure | None |
| 95-98% SI Structure | None |
| Year Proposed | 2020 |
| Year Recommended | NA |
| Companies | Kindred Biosciences |
| Conditions Approved | NA |
| Conditions Active | Canine atopic dermatitis |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | IL31 (Canine) |
| Package |
